Global Transdermal Microneedle System Market Growth 2025-2031

Publication ID:

LPI04256072

Publication Date:

April 24, 2025

Pages:

124

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Transdermal Microneedle System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Transdermal Microneedle System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Transdermal Microneedle System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Transdermal Microneedle System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Transdermal Microneedle System players cover KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淭ransdermal Microneedle System Industry Forecast鈥� looks at past sales and reviews total world Transdermal Microneedle System sales in 2024, providing a comprehensive analysis by region and market sector of projected Transdermal Microneedle System sales for 2025 through 2031. With Transdermal Microneedle System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transdermal Microneedle System industry.
This Insight Report provides a comprehensive analysis of the global Transdermal Microneedle System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transdermal Microneedle System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Transdermal Microneedle System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transdermal Microneedle System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transdermal Microneedle System.
This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Microneedle System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Segmentation by Application:
Drug Delivery
Vaccine Delivery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG
Key Questions Addressed in this Report
What is the 10-year outlook for the global Transdermal Microneedle System market?
What factors are driving Transdermal Microneedle System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Transdermal Microneedle System market opportunities vary by end market size?
How does Transdermal Microneedle System break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Microneedle System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Transdermal Microneedle System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Transdermal Microneedle System by Country/Region, 2020, 2024 & 2031
2.2 Transdermal Microneedle System Segment by Type
2.2.1 Hollow Microneedle Technology
2.2.2 Solid Microneedle Technology
2.2.3 Dissolving Microneedles Technology
2.3 Transdermal Microneedle System Sales by Type
2.3.1 Global Transdermal Microneedle System Sales Market Share by Type (2020-2025)
2.3.2 Global Transdermal Microneedle System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Transdermal Microneedle System Sale Price by Type (2020-2025)
2.4 Transdermal Microneedle System Segment by Application
2.4.1 Drug Delivery
2.4.2 Vaccine Delivery
2.5 Transdermal Microneedle System Sales by Application
2.5.1 Global Transdermal Microneedle System Sale Market Share by Application (2020-2025)
2.5.2 Global Transdermal Microneedle System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Transdermal Microneedle System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Transdermal Microneedle System Breakdown Data by Company
3.1.1 Global Transdermal Microneedle System Annual Sales by Company (2020-2025)
3.1.2 Global Transdermal Microneedle System Sales Market Share by Company (2020-2025)
3.2 Global Transdermal Microneedle System Annual Revenue by Company (2020-2025)
3.2.1 Global Transdermal Microneedle System Revenue by Company (2020-2025)
3.2.2 Global Transdermal Microneedle System Revenue Market Share by Company (2020-2025)
3.3 Global Transdermal Microneedle System Sale Price by Company
3.4 Key Manufacturers Transdermal Microneedle System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transdermal Microneedle System Product Location Distribution
3.4.2 Players Transdermal Microneedle System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Transdermal Microneedle System by Geographic Region
4.1 World Historic Transdermal Microneedle System Market Size by Geographic Region (2020-2025)
4.1.1 Global Transdermal Microneedle System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Transdermal Microneedle System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Transdermal Microneedle System Market Size by Country/Region (2020-2025)
4.2.1 Global Transdermal Microneedle System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Transdermal Microneedle System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transdermal Microneedle System Sales Growth
4.4 APAC Transdermal Microneedle System Sales Growth
4.5 Europe Transdermal Microneedle System Sales Growth
4.6 Middle East & Africa Transdermal Microneedle System Sales Growth
5 Americas
5.1 Americas Transdermal Microneedle System Sales by Country
5.1.1 Americas Transdermal Microneedle System Sales by Country (2020-2025)
5.1.2 Americas Transdermal Microneedle System Revenue by Country (2020-2025)
5.2 Americas Transdermal Microneedle System Sales by Type (2020-2025)
5.3 Americas Transdermal Microneedle System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transdermal Microneedle System Sales by Region
6.1.1 APAC Transdermal Microneedle System Sales by Region (2020-2025)
6.1.2 APAC Transdermal Microneedle System Revenue by Region (2020-2025)
6.2 APAC Transdermal Microneedle System Sales by Type (2020-2025)
6.3 APAC Transdermal Microneedle System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transdermal Microneedle System by Country
7.1.1 Europe Transdermal Microneedle System Sales by Country (2020-2025)
7.1.2 Europe Transdermal Microneedle System Revenue by Country (2020-2025)
7.2 Europe Transdermal Microneedle System Sales by Type (2020-2025)
7.3 Europe Transdermal Microneedle System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Microneedle System by Country
8.1.1 Middle East & Africa Transdermal Microneedle System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Transdermal Microneedle System Revenue by Country (2020-2025)
8.2 Middle East & Africa Transdermal Microneedle System Sales by Type (2020-2025)
8.3 Middle East & Africa Transdermal Microneedle System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transdermal Microneedle System
10.3 Manufacturing Process Analysis of Transdermal Microneedle System
10.4 Industry Chain Structure of Transdermal Microneedle System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transdermal Microneedle System Distributors
11.3 Transdermal Microneedle System Customer
12 World Forecast Review for Transdermal Microneedle System by Geographic Region
12.1 Global Transdermal Microneedle System Market Size Forecast by Region
12.1.1 Global Transdermal Microneedle System Forecast by Region (2026-2031)
12.1.2 Global Transdermal Microneedle System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Transdermal Microneedle System Forecast by Type (2026-2031)
12.7 Global Transdermal Microneedle System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 KINDEVA
13.1.1 KINDEVA Company Information
13.1.2 KINDEVA Transdermal Microneedle System Product Portfolios and Specifications
13.1.3 KINDEVA Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 KINDEVA Main Business Overview
13.1.5 KINDEVA Latest Developments
13.2 Zosano Pharma
13.2.1 Zosano Pharma Company Information
13.2.2 Zosano Pharma Transdermal Microneedle System Product Portfolios and Specifications
13.2.3 Zosano Pharma Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zosano Pharma Main Business Overview
13.2.5 Zosano Pharma Latest Developments
13.3 Becton-Dickinson(BD)Technologies
13.3.1 Becton-Dickinson(BD)Technologies Company Information
13.3.2 Becton-Dickinson(BD)Technologies Transdermal Microneedle System Product Portfolios and Specifications
13.3.3 Becton-Dickinson(BD)Technologies Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Becton-Dickinson(BD)Technologies Main Business Overview
13.3.5 Becton-Dickinson(BD)Technologies Latest Developments
13.4 Nanopass Technologies
13.4.1 Nanopass Technologies Company Information
13.4.2 Nanopass Technologies Transdermal Microneedle System Product Portfolios and Specifications
13.4.3 Nanopass Technologies Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Nanopass Technologies Main Business Overview
13.4.5 Nanopass Technologies Latest Developments
13.5 Corium
13.5.1 Corium Company Information
13.5.2 Corium Transdermal Microneedle System Product Portfolios and Specifications
13.5.3 Corium Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Corium Main Business Overview
13.5.5 Corium Latest Developments
13.6 Valeritas
13.6.1 Valeritas Company Information
13.6.2 Valeritas Transdermal Microneedle System Product Portfolios and Specifications
13.6.3 Valeritas Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Valeritas Main Business Overview
13.6.5 Valeritas Latest Developments
13.7 Nitto
13.7.1 Nitto Company Information
13.7.2 Nitto Transdermal Microneedle System Product Portfolios and Specifications
13.7.3 Nitto Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nitto Main Business Overview
13.7.5 Nitto Latest Developments
13.8 Microdermics
13.8.1 Microdermics Company Information
13.8.2 Microdermics Transdermal Microneedle System Product Portfolios and Specifications
13.8.3 Microdermics Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Microdermics Main Business Overview
13.8.5 Microdermics Latest Developments
13.9 TheraJect, Inc
13.9.1 TheraJect, Inc Company Information
13.9.2 TheraJect, Inc Transdermal Microneedle System Product Portfolios and Specifications
13.9.3 TheraJect, Inc Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 TheraJect, Inc Main Business Overview
13.9.5 TheraJect, Inc Latest Developments
13.10 Vaxxas
13.10.1 Vaxxas Company Information
13.10.2 Vaxxas Transdermal Microneedle System Product Portfolios and Specifications
13.10.3 Vaxxas Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Vaxxas Main Business Overview
13.10.5 Vaxxas Latest Developments
13.11 Lohmann Therapie-Systeme AG
13.11.1 Lohmann Therapie-Systeme AG Company Information
13.11.2 Lohmann Therapie-Systeme AG Transdermal Microneedle System Product Portfolios and Specifications
13.11.3 Lohmann Therapie-Systeme AG Transdermal Microneedle System Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lohmann Therapie-Systeme AG Main Business Overview
13.11.5 Lohmann Therapie-Systeme AG Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂